PARI Respiratory Equipment, a worldwide developer and manufacturer of aerosol delivery systems, won a 2015 American Package Design Award for Kitabis Pak®.
Kitabis Pak, approved by the FDA last December, is reportedly the first co-packaging of generic tobramycin inhalation solution with a PARI LC PLUS® Nebulizer for patients with cystic fibrosis.
"This award highlights all the hard work we put into this unique product offering of nebulized drug and device,” says Jan Zimmermann, Portfolio Manager for Kitabis Pak. “In creating a package that is easy for patients to use, we also wanted to convey that the components suit each other. By using complimentary colors, the packaging visually reflects the fact that tobramycin inhalation solution was designed to be delivered by the PARI LC PLUS Nebulizer.”
"Not only is the packaging attractive, it ensures that with every prescription, every patient has access to the only FDA-approved nebulizer handset for tobramycin inhalation solution and the same nebulizer used in clinical trials. It is gratifying that the creative package for this important combination of therapy and delivery device puts us alongside other design winners, such as Target, Burt's Bees, Revlon, and Tory Burch," says Ashley Weigand, Director of Marketing for PARI Respiratory Equipment.
PARI Respiratory Equipment exclusively markets Kitabis Pak and the compressor access program called PARI PROVIDE. Kitabis Pak is a new standard for nebulized drugs similar to asthma & COPD inhalers where the drug and device are prescribed and dispensed together. PARI PROVIDE takes the program one step further by providing patients with the only FDA-approved compressor to deliver tobramycin inhalation solution.
Full product and prescribing information on Kitabis Pak and PARI PROVIDE is available online.
